discovered that B7-H3 enhances chemoresistance in breast cancer cells by activating the Jak2/Stat3 signaling pathway, thereby reducing the sensitivity of breast cancer cells to paclitaxel (85). This evidence concerns the gene JAK2 and breast cancer.